Literature DB >> 18598115

Intrauterine restriction (IUGR).

Giampaolo Mandruzzato1, Aris Antsaklis, Francesc Botet, Frank A Chervenak, Francisc Figueras, Amos Grunebaum, Bienve Puerto, Daniel Skupski, Milan Stanojevic.   

Abstract

Perinatal mortality and morbidity is markedly increased in intrauterine growth restricted (IUGR) fetuses. Prenatal identification of IUGR is the first step in clinical management. For that purpose a uniform definition and criteria are required. The etiology of IUGR is multifactorial and whenever possible it should be assessed. When the cause is of placental origin, it is possible to identify the affected fetuses. The major complication is chronic fetal hypoxemia. By monitoring the changes of fetal vital functions it is thus possible to improve both management and outcome. The timing of delivery is crucial but the optimal management scheme has not yet been identified. When IUGR is identified at very early gestational ages, serial assessments of the risk of continuing the in utero fetal life under adverse conditions versus the risks of the prematurity should be performed. Delivery of IUGR fetuses should take place in centers where appropriate neonatal assistance can be provided. Careful monitoring of the IUGR fetus during labor is crucial as the IUGR fetus can quickly decompensate once uterine contractions have started.

Entities:  

Mesh:

Year:  2008        PMID: 18598115     DOI: 10.1515/JPM.2008.050

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  39 in total

1.  Intrauterine Growth Restriction Is Associated with Unique Features of the Reproductive Microbiome.

Authors:  Jianzhong Hu; Paula Benny; Michelle Wang; Yula Ma; Luca Lambertini; Inga Peter; Yajuan Xu; Men-Jean Lee
Journal:  Reprod Sci       Date:  2020-10-26       Impact factor: 3.060

2.  Intrauterine Growth Restriction and Hyperoxia as a Cause of White Matter Injury.

Authors:  Jill L Chang; Mirrah Bashir; Christiana Santiago; Kathryn Farrow; Camille Fung; Ashley S Brown; Robert W Dettman; Maria L V Dizon
Journal:  Dev Neurosci       Date:  2018-11-14       Impact factor: 2.984

Review 3.  Impact of exercise during pregnancy on gestational weight gain and birth weight: an overview.

Authors:  Marina Vargas-Terrones; Taniya S Nagpal; Ruben Barakat
Journal:  Braz J Phys Ther       Date:  2018-11-22       Impact factor: 3.377

4.  Pregnancy and beta-thalassemia: an Italian multicenter experience.

Authors:  Raffaella Origa; Antonio Piga; Giovanni Quarta; Gian Luca Forni; Filomena Longo; Angela Melpignano; Renzo Galanello
Journal:  Haematologica       Date:  2009-11-10       Impact factor: 9.941

5.  Pregnancy Outcomes in Women with Homozygous Beta Thalassaemia: A single-centre experience from Oman.

Authors:  Nihal Al-Riyami; Maha Al-Khaduri; Shahina Daar
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

6.  Prophylactic Low Molecular Weight Heparin Improving Perinatal Outcome in Non-thrombophilic Placental-Mediated Complications.

Authors:  Shweta Singh; Renuka Sinha; Mayank Kaushik
Journal:  J Obstet Gynaecol India       Date:  2015-07-09

7.  DNA hypermethylation of CD3(+) T cells from cord blood of infants exposed to intrauterine growth restriction.

Authors:  Lyda Williams; Yoshinori Seki; Fabien Delahaye; Alex Cheng; Mamta Fuloria; Francine Hughes Einstein; Maureen J Charron
Journal:  Diabetologia       Date:  2016-05-17       Impact factor: 10.122

8.  Effects of intrauterine growth retardation and Bacillus subtilis PB6 supplementation on growth performance, intestinal development and immune function of piglets during the suckling period.

Authors:  Liang Hu; Xie Peng; Hong Chen; Chuan Yan; Yan Liu; Qin Xu; Zhengfeng Fang; Yan Lin; Shengyu Xu; Bin Feng; Jian Li; Lianqiang Che
Journal:  Eur J Nutr       Date:  2016-05-17       Impact factor: 5.614

9.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Amy E Whitten; Steven J Korzeniewski; Piya Chaemsaithong; Edgar Hernandez-Andrade; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2016

10.  Uteroplacental adenovirus vascular endothelial growth factor gene therapy increases fetal growth velocity in growth-restricted sheep pregnancies.

Authors:  David J Carr; Jacqueline M Wallace; Raymond P Aitken; John S Milne; Vedanta Mehta; John F Martin; Ian C Zachary; Donald M Peebles; Anna L David
Journal:  Hum Gene Ther       Date:  2014-04-07       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.